A
Abingworth Portfolio holdings
AUM
$307M
This Quarter Return
+26.78%
1 Year Return
+93.6%
3 Year Return
+207.29%
5 Year Return
+452.78%
10 Year Return
–
AUM
$144M
AUM Growth
+$144M
(+15%)
Cap. Flow
-$7.32M
Cap. Flow
% of AUM
-5.07%
Top 10 Holdings %
Top 10 Hldgs %
90.35%
Holding
19
New
3
Increased
–
Reduced
3
Closed
1
Top Buys
1 |
OBSV
ObsEva SA Ordinary Shares
OBSV
|
$3.48M |
2 |
ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
|
$2.78M |
3 |
Ultragenyx Pharmaceutical
RARE
|
$2.03M |
Top Sells
1 |
CRISPR Therapeutics
CRSP
|
$8.43M |
2 |
PRTK
Paratek Pharmaceuticals, Inc.
PRTK
|
$6.51M |
3 |
CBAY
Cymabay Therapeutics
CBAY
|
$461K |
4 |
NOVN
Novan, Inc. Common Stock
NOVN
|
$215K |
Sector Composition
1 | Healthcare | 95.11% |